Drawing for ELLUME

USPTO serial 79312805

ELLUME

Reviewed by CopyMark Law Group

Reg. 6886477Status 700Registered
Filing date
Status date
Registration date
Nov 1, 2022
Examiner
SALES, HEATHER ALISON
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ELLUME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael A. Bondi

Michael A. Bondi Moss & Barnett100 South Fifth Street, Suite 2500Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of influenza, coronavirus and infectious diseases; medicinal preparations for the treatment of influenza, coronavirus and infectious diseases; diagnostic preparations for medical purposes; diagnostic reagents for medical use; chemical analysers for medical use, namely, medical diagnostic reagents, assays, solutions and buffers for testing and analysis of blood or bodily fluids for use in disease detection; chemical products for immunoassay use, namely, immunoassay reagents for medical use; immunoassay reagents for medical useACTIVE
009Computer hardware and downloadable computer software for medical purposes in the nature of medical diagnostic testing; Computer hardware and downloadable computer software for medical screening, testing, diagnosis, treatment and reporting; computer hardware being a hand-held digital device for medical diagnostic testing, namely, a handheld computer; computer hardware being a hand-held digital device for diagnosing influenza, coronavirus and other infectious diseases, namely, a handheld computer; downloadable application software for use with medical tests for diagnosing influenza, coronavirus and other infectious diseases; readers, namely, data processing equipment; optical readersACTIVE
010Medical apparatus, namely, medical diagnostic apparatus for testing of blood or bodily fluids for use in infectious disease detection; medical apparatus, namely, medical diagnostic apparatus for testing of blood or bodily fluids for the detection of antibodies; diagnostic medical apparatus for testing for infectious diseases; analysers for medical use, namely, medical instruments for detecting and analysing virus in the body; analysers for virus identification for medical purposes, namely, medical instruments for detecting and analysing virus in the body; medical assay apparatus, namely, medical diagnostic apparatus for detection of infectious diseases; diagnostic test kits consisting primarily of probes, buffers and reagents for testing and analysis of blood or bodily fluids for the detection of infectious diseasesACTIVE
042Design and development of medical diagnostic products; design and development of medical diagnostic products for the diagnosis of infectious diseases; providing temporary use of non-downloadable web-based software for medical screening, testing, diagnosis, treatment and reporting of results; provision of online non-downloadable software for use with medical tests for diagnosing infectious diseases; provision of online non-downloadable software for use with medical tests for diagnosing influenza, coronavirus and other infectious diseases; provision of online non-downloadable computer software for medical screening, testing, diagnosis, treatment and reporting of resultsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 8, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 8, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 8, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 8, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 14, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Feb 22, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB
Feb 22, 2023FIMPFINAL DISPOSITION PROCESSED
Feb 1, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 1, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 1, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 23, 2022GPNXNOTIFICATION PROCESSED BY IB
Aug 16, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 16, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 27, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 27, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 27, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 8, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 30, 2022XAECEXAMINER'S AMENDMENT ENTERED
Jun 30, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 30, 2022GNEAEXAMINERS AMENDMENT E-MAILED
Jun 30, 2022CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 16, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 15, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 15, 2022RFNTREFUSAL PROCESSED BY IB
Dec 27, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 27, 2021RFRRREFUSAL PROCESSED BY MPU
Dec 2, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 1, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 30, 2021DOCKASSIGNED TO EXAMINER
Jun 15, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jun 11, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 10, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance